Increased Programmed Death-1 Expression on CD4+ T Cells in Cutaneous T-Cell Lymphoma
Archives of Dermatology2010Vol. 146(12), pp. 1382–1382
Citations Over TimeTop 10% of 2010 papers
Sara Samimi, Bernice Benoit, Katherine G. Evans, E. John Wherry, Louise C. Showe, Maria Wysocka, Alain H. Rook
Abstract
Our data imply that increased PD-1 expression in Sézary syndrome may play a role in attenuating the immune response and provide further insight into the immunosuppressive nature of CD4(+) T cells in Sézary syndrome and suggest another potential means of targeted therapy for these patients.
Related Papers
- → Cyclosporine in the treatment of cutaneous T cell lymphoma(1990)25 cited
- → ADVANCES IN THE MANAGEMENT OF CUTANEOUS T-CELL LYMPHOMA(1998)16 cited
- → Cutaneous T-cell lymphoma (mycosis fungoides)(1996)9 cited
- → Efficacy of chlormethine gel in patients with stage I–IIA mycosis fungoides cutaneous T-cell lymphoma (MF-CTCL): re-analysis of a randomized phase 2 study(2019)
- → Efficacy and quality of life (QoL) in patients with mycosis fungoides cutaneous T-cell lymphoma (MF-CTCL) treated with chlormethine gel and other therapies: results from the PROVe study(2019)